Your Doctor Is Most Likely Consulting This Free AI Chatbot, Report Says
How would you like it if, when stumped or just in need of some help with an unfamiliar situation, your doctor consulted a free, ad-supported AI chatbot? That’s not actually a hypothetical. They probably are doing that, a new report from NBC News says.
It’s called OpenEvidence, and NBC says it was “used by about 65% of U.S. doctors across almost 27 million clinical encounters in April alone.” An earlier Bloomberg report on OpenEvidence from seven months ago said it had signed up 50% of American doctors at the time—so reported growth is rapid.
The OpenEvidence homepage trumpets the bot as “America’s Official Medical Knowledge Platform,” and says healthcare professionals qualify for unlimited free use, but non-doctors can try it for free without creating accounts. It gives long, detailed answers with extensive citations that superficially look—to me, a non-doctor—trustworthy and credible.
NBC interviewed doctors for its story, and apparently pressed them on how often they actually click those links to the sources of information, and “most said they only do so when they get an unexpected result,” NBC’s report says.
While it’s free, OpenEvidence is not a charity. It’s a Miami-headquartered tech unicorn with a billionaire founder named David Nadler, and as of January it boasted a $12 billion valuation. NBC says it’s backed by some of the all stars of Sand Hill Road: Sequoia Capital and Andreessen Horowitz, along with Google Ventures, Thrive Capital, and Nvidia.
And its revenue comes from ads (for now), which NBC says are often for “pharmaceutical and medical device companies.”
I’m not capable of stress testing such a piece of software, but I kicked the tires slightly by asking Claude to generate doctor’s notes that are very bad and irresponsible (I said it was just a movie prop).
When I told OpenEvidence those were my notes and asked it to make sure they were good, thankfully, it confirmed that they were bad, saying in part:
“This clinical documentation raises serious patient safety concerns. The presentation described contains multiple red flags for subarachnoid hemorrhage (SAH) that appear to have been insufficiently weighted, and the current management plan could result in significant harm.”
So that’s somewhat comforting.
On the other hand, according to NBC:
“[…]some healthcare providers were quick to point out that OpenEvidence occasionally flubbed or exaggerated its answers, particularly on rare conditions or in ‘edge’ cases.”
NBC’s report also clocked some worries within the medical community and elsewhere, in particular, a “lack of rigorous scientific studies on the tool’s patient impact,” and signs that OpenEvidence might be stunting the intellectual development of recent med school grads:
“One midcareer doctor in Missouri, who requested anonymity given the limited number of providers in their medical field in the country, said he was already seeing the detrimental effects of OpenEvidence on students’ ability to sort signals from noise.
‘My worry is that when we introduce a new tool, any kind of tool that is doing part of your skills that you had trained up for a while beforehand, you start losing those skills pretty quickly”
At a recent doctor’s appointment, my doctor asked my permission to use an AI tool on their phone (I don’t know if it was OpenEvidence). I didn’t know what to say other than yes. Do I want that for my doctor’s appointment? Not especially. But if my doctor has come to rely on a tool like this, then what am I supposed to do? Take away their crutch?
How would you like it if, when stumped or just in need of some help with an unfamiliar situation, your doctor consulted a free, ad-supported AI chatbot? That’s not actually a hypothetical. They probably are doing that, a new report from NBC News says.
It’s called OpenEvidence, and NBC says it was “used by about 65% of U.S. doctors across almost 27 million clinical encounters in April alone.” An earlier Bloomberg report on OpenEvidence from seven months ago said it had signed up 50% of American doctors at the time—so reported growth is rapid.
The OpenEvidence homepage trumpets the bot as “America’s Official Medical Knowledge Platform,” and says healthcare professionals qualify for unlimited free use, but non-doctors can try it for free without creating accounts. It gives long, detailed answers with extensive citations that superficially look—to me, a non-doctor—trustworthy and credible.
NBC interviewed doctors for its story, and apparently pressed them on how often they actually click those links to the sources of information, and “most said they only do so when they get an unexpected result,” NBC’s report says.
While it’s free, OpenEvidence is not a charity. It’s a Miami-headquartered tech unicorn with a billionaire founder named David Nadler, and as of January it boasted a $12 billion valuation. NBC says it’s backed by some of the all stars of Sand Hill Road: Sequoia Capital and Andreessen Horowitz, along with Google Ventures, Thrive Capital, and Nvidia.
And its revenue comes from ads (for now), which NBC says are often for “pharmaceutical and medical device companies.”
I’m not capable of stress testing such a piece of software, but I kicked the tires slightly by asking Claude to generate doctor’s notes that are very bad and irresponsible (I said it was just a movie prop).
When I told OpenEvidence those were my notes and asked it to make sure they were good, thankfully, it confirmed that they were bad, saying in part:
“This clinical documentation raises serious patient safety concerns. The presentation described contains multiple red flags for subarachnoid hemorrhage (SAH) that appear to have been insufficiently weighted, and the current management plan could result in significant harm.”
So that’s somewhat comforting.
On the other hand, according to NBC:
“[…]some healthcare providers were quick to point out that OpenEvidence occasionally flubbed or exaggerated its answers, particularly on rare conditions or in ‘edge’ cases.”
NBC’s report also clocked some worries within the medical community and elsewhere, in particular, a “lack of rigorous scientific studies on the tool’s patient impact,” and signs that OpenEvidence might be stunting the intellectual development of recent med school grads:
“One midcareer doctor in Missouri, who requested anonymity given the limited number of providers in their medical field in the country, said he was already seeing the detrimental effects of OpenEvidence on students’ ability to sort signals from noise.
‘My worry is that when we introduce a new tool, any kind of tool that is doing part of your skills that you had trained up for a while beforehand, you start losing those skills pretty quickly”
At a recent doctor’s appointment, my doctor asked my permission to use an AI tool on their phone (I don’t know if it was OpenEvidence). I didn’t know what to say other than yes. Do I want that for my doctor’s appointment? Not especially. But if my doctor has come to rely on a tool like this, then what am I supposed to do? Take away their crutch?
Source link
#Doctor #Consulting #Free #Chatbot #Report
ASUS has unveiled the Ascent QN10, a new mini PC that brings premium desktop capabilities into a compact form factor. This device comes equipped with all the benefits of a desktop computer, packed in a compact design. ASUS has managed to pack the device with all the essential functionalities through its integration with the powerful Snapdragon X2 Elite processor. The compact size of the product also allows users to use it in any residential or office setting.
Asus Ascent QN10 Specifications
As for the hardware specifications, the ASUS Ascent QN10 comes with the powerful Snapdragon X2 Elite processor from Qualcomm to deliver contemporary computing capabilities. The on-board NPU offers up to 80 TOPS computing capabilities. The processing unit also performs various tasks and runs everyday applications easily. ASUS calls this device the first mini PC to feature this chipset and run both versions of Windows 11.
It supports a range of AI models, agents, and orchestration tools. Compatible applications include OpenClaw, Hermes, Cursor, Claude Desktop, OpenAI Codex, and OpenCode. Running AI tasks locally helps reduce delays and keeps more data on the device. This can benefit users who work with coding, content creation, and AI development.
The mini PC features a silver finish and a space-saving 0.75L chassis. ASUS says the design is 86% smaller than a conventional 5L mini PC. The front section includes the ASUS branding and power button, while side vents support cooling. The mini PC measures around 130×130×39.96mm and weighs only 0.75kg, along with ventilation vents along the side to improve cooling.
ASUS places multiple USB Type-A and Type-C ports on the device, including USB 4 Gen 2 connections. The front panel provides easy access to frequently used ports. The mini PC also features an HDMI port, Ethernet connection, and a 3.5 mm audio connector. ASUS provides the Ascent QN10 with an 180W power supply along with a sleek design. The mini PC is ideal for use in offices, content creation, coding, and AI-based tasks. The small form factor not only decreases desktop clutter but also ensures desktop-like performance.
Price And Availability
The ASUS Ascent QN10 has yet to be officially announced regarding pricing and availability. ASUS is expected to provide more details about the mini PC’s launch in the coming days. As of today, ASUS has simply introduced it as part of their mini PC range.
ASUS has unveiled the Ascent QN10, a new mini PC that brings premium desktop capabilities into a compact form factor. This device comes equipped with all the benefits of a desktop computer, packed in a compact design. ASUS has managed to pack the device with all the essential functionalities through its integration with the powerful Snapdragon X2 Elite processor. The compact size of the product also allows users to use it in any residential or office setting.
Asus Ascent QN10 Specifications
As for the hardware specifications, the ASUS Ascent QN10 comes with the powerful Snapdragon X2 Elite processor from Qualcomm to deliver contemporary computing capabilities. The on-board NPU offers up to 80 TOPS computing capabilities. The processing unit also performs various tasks and runs everyday applications easily. ASUS calls this device the first mini PC to feature this chipset and run both versions of Windows 11.
It supports a range of AI models, agents, and orchestration tools. Compatible applications include OpenClaw, Hermes, Cursor, Claude Desktop, OpenAI Codex, and OpenCode. Running AI tasks locally helps reduce delays and keeps more data on the device. This can benefit users who work with coding, content creation, and AI development.
The mini PC features a silver finish and a space-saving 0.75L chassis. ASUS says the design is 86% smaller than a conventional 5L mini PC. The front section includes the ASUS branding and power button, while side vents support cooling. The mini PC measures around 130×130×39.96mm and weighs only 0.75kg, along with ventilation vents along the side to improve cooling.
ASUS places multiple USB Type-A and Type-C ports on the device, including USB 4 Gen 2 connections. The front panel provides easy access to frequently used ports. The mini PC also features an HDMI port, Ethernet connection, and a 3.5 mm audio connector. ASUS provides the Ascent QN10 with an 180W power supply along with a sleek design. The mini PC is ideal for use in offices, content creation, coding, and AI-based tasks. The small form factor not only decreases desktop clutter but also ensures desktop-like performance.
Price And Availability
The ASUS Ascent QN10 has yet to be officially announced regarding pricing and availability. ASUS is expected to provide more details about the mini PC’s launch in the coming days. As of today, ASUS has simply introduced it as part of their mini PC range.
#ASUS #Unveils #Ascent #QN10 #Mini #Powered #Snapdragon #EliteAsus">ASUS Unveils Ascent QN10 Mini PC Powered by Snapdragon X2 Elite
ASUS has unveiled the Ascent QN10, a new mini PC that brings premium desktop capabilities into a compact form factor. This device comes equipped with all the benefits of a desktop computer, packed in a compact design. ASUS has managed to pack the device with all the essential functionalities through its integration with the powerful Snapdragon X2 Elite processor. The compact size of the product also allows users to use it in any residential or office setting.
Asus Ascent QN10 Specifications
As for the hardware specifications, the ASUS Ascent QN10 comes with the powerful Snapdragon X2 Elite processor from Qualcomm to deliver contemporary computing capabilities. The on-board NPU offers up to 80 TOPS computing capabilities. The processing unit also performs various tasks and runs everyday applications easily. ASUS calls this device the first mini PC to feature this chipset and run both versions of Windows 11.
It supports a range of AI models, agents, and orchestration tools. Compatible applications include OpenClaw, Hermes, Cursor, Claude Desktop, OpenAI Codex, and OpenCode. Running AI tasks locally helps reduce delays and keeps more data on the device. This can benefit users who work with coding, content creation, and AI development.
The mini PC features a silver finish and a space-saving 0.75L chassis. ASUS says the design is 86% smaller than a conventional 5L mini PC. The front section includes the ASUS branding and power button, while side vents support cooling. The mini PC measures around 130×130×39.96mm and weighs only 0.75kg, along with ventilation vents along the side to improve cooling.
ASUS places multiple USB Type-A and Type-C ports on the device, including USB 4 Gen 2 connections. The front panel provides easy access to frequently used ports. The mini PC also features an HDMI port, Ethernet connection, and a 3.5 mm audio connector. ASUS provides the Ascent QN10 with an 180W power supply along with a sleek design. The mini PC is ideal for use in offices, content creation, coding, and AI-based tasks. The small form factor not only decreases desktop clutter but also ensures desktop-like performance.
Price And Availability
The ASUS Ascent QN10 has yet to be officially announced regarding pricing and availability. ASUS is expected to provide more details about the mini PC’s launch in the coming days. As of today, ASUS has simply introduced it as part of their mini PC range.
No matter what you thought about The Acolyte season one, there is no denying that season two was going to be incredible. Creator Leslye Headland and her team ended that first season with the promise of exploring multiple Dark Side relationships, the reveal of potentially the ultimate Sith in Darth Plagueis, a deep dive into the corruption of the Jedi, and even Yoda’s complicity in it. But, of course, that didn’t happen.
Instead, Disney decided not to move forward with more episodes of The Acolyte. A true disappointment to fans of the show, but not all that surprising. The show, of course, had invited all manner of vitriol, and it seems like viewership didn’t quite justify the cost of more episodes. However, in the years since, the show has endured. In fact, just recently, there were reports that it once again cracked the top 10 on Disney+. And, in a new interview, Headland said that she’d still be interested in returning to a galaxy far, far, away.
“I would still want to do it! Absolutely,” she told Empire, via Fantha Tracks. “As more people discover it, I think people may want to see some form of the story come back. We did have a lot of stuff that we wanted to explore, including tying in lore to the sequels. Getting into who exactly Manny [Jacinto]’s character is, his connection with [Jedi Master] Vernestra, his connection with [Sith Lord] Plagueis, and then his connection with other sequel-established things.”
Headland went on to say that she’s also felt the show returning a bit in recent days. “I’m having a resurgence of The Acolyte in my real life,” she said. “I speak with people who are really big fans, and were disappointed in the cancellation. was like, I went to a play last night, and somebody ‘I just have to tell you that I loved it.’”
We loved it too and think a second season would be absolutely incredible. Who wouldn’t want to see The Stranger with his new apprentice, and how that works with his master, Plagueis? Or what lengths the Jedi will go to in order to cover it all up?
No matter what you thought about The Acolyte season one, there is no denying that season two was going to be incredible. Creator Leslye Headland and her team ended that first season with the promise of exploring multiple Dark Side relationships, the reveal of potentially the ultimate Sith in Darth Plagueis, a deep dive into the corruption of the Jedi, and even Yoda’s complicity in it. But, of course, that didn’t happen.
Instead, Disney decided not to move forward with more episodes of The Acolyte. A true disappointment to fans of the show, but not all that surprising. The show, of course, had invited all manner of vitriol, and it seems like viewership didn’t quite justify the cost of more episodes. However, in the years since, the show has endured. In fact, just recently, there were reports that it once again cracked the top 10 on Disney+. And, in a new interview, Headland said that she’d still be interested in returning to a galaxy far, far, away.
“I would still want to do it! Absolutely,” she told Empire, via Fantha Tracks. “As more people discover it, I think people may want to see some form of the story come back. We did have a lot of stuff that we wanted to explore, including tying in lore to the sequels. Getting into who exactly Manny [Jacinto]’s character is, his connection with [Jedi Master] Vernestra, his connection with [Sith Lord] Plagueis, and then his connection with other sequel-established things.”
Headland went on to say that she’s also felt the show returning a bit in recent days. “I’m having a resurgence of The Acolyte in my real life,” she said. “I speak with people who are really big fans, and were disappointed in the cancellation. was like, I went to a play last night, and somebody ‘I just have to tell you that I loved it.’”
We loved it too and think a second season would be absolutely incredible. Who wouldn’t want to see The Stranger with his new apprentice, and how that works with his master, Plagueis? Or what lengths the Jedi will go to in order to cover it all up?
#Hey #Dave #Filoni #Leslye #Headland #Acolyte #SeasonDave Filoni,Leslye Headland,Star Wars,The Acolyte">Hey Dave Filoni, Leslye Headland Is Still Down for ‘The Acolyte’ Season 2
No matter what you thought about The Acolyte season one, there is no denying that season two was going to be incredible. Creator Leslye Headland and her team ended that first season with the promise of exploring multiple Dark Side relationships, the reveal of potentially the ultimate Sith in Darth Plagueis, a deep dive into the corruption of the Jedi, and even Yoda’s complicity in it. But, of course, that didn’t happen.
Instead, Disney decided not to move forward with more episodes of The Acolyte. A true disappointment to fans of the show, but not all that surprising. The show, of course, had invited all manner of vitriol, and it seems like viewership didn’t quite justify the cost of more episodes. However, in the years since, the show has endured. In fact, just recently, there were reports that it once again cracked the top 10 on Disney+. And, in a new interview, Headland said that she’d still be interested in returning to a galaxy far, far, away.
“I would still want to do it! Absolutely,” she told Empire, via Fantha Tracks. “As more people discover it, I think people may want to see some form of the story come back. We did have a lot of stuff that we wanted to explore, including tying in lore to the sequels. Getting into who exactly Manny [Jacinto]’s character is, his connection with [Jedi Master] Vernestra, his connection with [Sith Lord] Plagueis, and then his connection with other sequel-established things.”
Headland went on to say that she’s also felt the show returning a bit in recent days. “I’m having a resurgence of The Acolyte in my real life,” she said. “I speak with people who are really big fans, and were disappointed in the cancellation. was like, I went to a play last night, and somebody ‘I just have to tell you that I loved it.’”
We loved it too and think a second season would be absolutely incredible. Who wouldn’t want to see The Stranger with his new apprentice, and how that works with his master, Plagueis? Or what lengths the Jedi will go to in order to cover it all up?
Don’t know what to get the travel bug in your life? While planning a surprise vacay for them may not be the most practical gift, a Hotels.com gift card can be a thoughtful way to help ease the financial burden of their next vacation. Plus, you can save 10% when you buy a Hotels.com gift card of $150 or more.
Score Hotels.com Coupon Code for App-Exclusive Deals
Another easy way to save on your next vacation or stay is by booking through the Hotels.com app, which has rotating app-exclusive deals and flash sales when you book your next stay on the Hotels.com mobile app.
Don’t know what to get the travel bug in your life? While planning a surprise vacay for them may not be the most practical gift, a Hotels.com gift card can be a thoughtful way to help ease the financial burden of their next vacation. Plus, you can save 10% when you buy a Hotels.com gift card of $150 or more.
Score Hotels.com Coupon Code for App-Exclusive Deals
Another easy way to save on your next vacation or stay is by booking through the Hotels.com app, which has rotating app-exclusive deals and flash sales when you book your next stay on the Hotels.com mobile app.
#Top #Hotels.com #Coupon #Codes #Junecoupons,shopping">Top Best Hotels.com Coupon Codes for June 2026
Traveling can be complicated, especially if you’re planning a last-minute trip. Hotels.com has hotel deals at thousands of hotels around the world, plus special members-only pricing when you join the free OneKey rewards program. You can save on flights and transportation, too, so everything you need for your next trip is ready to go on Hotels.com. It’s easy to find a place to stay, and save some major cash in the process, especially with this Hotels.com coupon.
Save Big, With or Without a Hotels.com Coupons at WIRED
Right now, Hotels.com OneKey members can get up to 30% off their stay with deals on hotels or hotels bundled with flights. Savings get better the higher your membership tier, but even the free membership offers great pricing to guarantee a great trip before it even starts. But while Hotels.com deals are amazing on their own, nothing beats the savings you can get with a good old-fashioned coupon for Hotels.com.
Top Hotels.com Coupon Deals Verified by the WIRED Team
Be sure to check out Hotels.com often for a wide selection of Hotel.com coupons and other deals available for booking in May 2026 and beyond. So whether you’re planning your next hotel stay for summer vacation, or need to book transportation for that upcoming wedding, a Hotels.com coupon can help you save on your next vacay.
Unlock Hotels.com Savings on Last-Minute Bookings
I’m always looking to become more spontaneous. But it’s difficult when booking at the last minute can be confusing or pricey. Not on Hotels.com, though! You can save 20% or more on spontaneous city breaks and last-minute getaways when you book travel within the next two weeks with these Hotels.com offers.
How to Buy Hotels.com Gift Cards at 10% Off
Don’t know what to get the travel bug in your life? While planning a surprise vacay for them may not be the most practical gift, a Hotels.com gift card can be a thoughtful way to help ease the financial burden of their next vacation. Plus, you can save 10% when you buy a Hotels.com gift card of $150 or more.
Score Hotels.com Coupon Code for App-Exclusive Deals
Another easy way to save on your next vacation or stay is by booking through the Hotels.com app, which has rotating app-exclusive deals and flash sales when you book your next stay on the Hotels.com mobile app.
![Your Doctor Is Most Likely Consulting This Free AI Chatbot, Report Says
How would you like it if, when stumped or just in need of some help with an unfamiliar situation, your doctor consulted a free, ad-supported AI chatbot? That’s not actually a hypothetical. They probably are doing that, a new report from NBC News says. It’s called OpenEvidence, and NBC says it was “used by about 65% of U.S. doctors across almost 27 million clinical encounters in April alone.” An earlier Bloomberg report on OpenEvidence from seven months ago said it had signed up 50% of American doctors at the time—so reported growth is rapid.
The OpenEvidence homepage trumpets the bot as “America’s Official Medical Knowledge Platform,” and says healthcare professionals qualify for unlimited free use, but non-doctors can try it for free without creating accounts. It gives long, detailed answers with extensive citations that superficially look—to me, a non-doctor—trustworthy and credible. NBC interviewed doctors for its story, and apparently pressed them on how often they actually click those links to the sources of information, and “most said they only do so when they get an unexpected result,” NBC’s report says.
While it’s free, OpenEvidence is not a charity. It’s a Miami-headquartered tech unicorn with a billionaire founder named David Nadler, and as of January it boasted a billion valuation. NBC says it’s backed by some of the all stars of Sand Hill Road: Sequoia Capital and Andreessen Horowitz, along with Google Ventures, Thrive Capital, and Nvidia.
And its revenue comes from ads (for now), which NBC says are often for “pharmaceutical and medical device companies.” I’m not capable of stress testing such a piece of software, but I kicked the tires slightly by asking Claude to generate doctor’s notes that are very bad and irresponsible (I said it was just a movie prop). ©OpenEvidence When I told OpenEvidence those were my notes and asked it to make sure they were good, thankfully, it confirmed that they were bad, saying in part:
“This clinical documentation raises serious patient safety concerns. The presentation described contains multiple red flags for subarachnoid hemorrhage (SAH) that appear to have been insufficiently weighted, and the current management plan could result in significant harm.” So that’s somewhat comforting. On the other hand, according to NBC: “[…]some healthcare providers were quick to point out that OpenEvidence occasionally flubbed or exaggerated its answers, particularly on rare conditions or in ‘edge’ cases.” NBC’s report also clocked some worries within the medical community and elsewhere, in particular, a “lack of rigorous scientific studies on the tool’s patient impact,” and signs that OpenEvidence might be stunting the intellectual development of recent med school grads: “One midcareer doctor in Missouri, who requested anonymity given the limited number of providers in their medical field in the country, said he was already seeing the detrimental effects of OpenEvidence on students’ ability to sort signals from noise. ‘My worry is that when we introduce a new tool, any kind of tool that is doing part of your skills that you had trained up for a while beforehand, you start losing those skills pretty quickly” At a recent doctor’s appointment, my doctor asked my permission to use an AI tool on their phone (I don’t know if it was OpenEvidence). I didn’t know what to say other than yes. Do I want that for my doctor’s appointment? Not especially. But if my doctor has come to rely on a tool like this, then what am I supposed to do? Take away their crutch? #Doctor #Consulting #Free #Chatbot #ReportArtificial intelligence,doctors,Medicine](https://i0.wp.com/gizmodo.com/app/uploads/2026/05/Screenshot-2026-05-13-at-8.02.01 PM.jpg?ssl=1 "Your Doctor Is Most Likely Consulting This Free AI Chatbot, Report Says
How would you like it if, when stumped or just in need of some help with an unfamiliar situation, your doctor consulted a free, ad-supported AI chatbot? That’s not actually a hypothetical. They probably are doing that, a new report from NBC News says. It’s called OpenEvidence, and NBC says it was “used by about 65% of U.S. doctors across almost 27 million clinical encounters in April alone.” An earlier Bloomberg report on OpenEvidence from seven months ago said it had signed up 50% of American doctors at the time—so reported growth is rapid.
The OpenEvidence homepage trumpets the bot as “America’s Official Medical Knowledge Platform,” and says healthcare professionals qualify for unlimited free use, but non-doctors can try it for free without creating accounts. It gives long, detailed answers with extensive citations that superficially look—to me, a non-doctor—trustworthy and credible. NBC interviewed doctors for its story, and apparently pressed them on how often they actually click those links to the sources of information, and “most said they only do so when they get an unexpected result,” NBC’s report says.
While it’s free, OpenEvidence is not a charity. It’s a Miami-headquartered tech unicorn with a billionaire founder named David Nadler, and as of January it boasted a billion valuation. NBC says it’s backed by some of the all stars of Sand Hill Road: Sequoia Capital and Andreessen Horowitz, along with Google Ventures, Thrive Capital, and Nvidia.
And its revenue comes from ads (for now), which NBC says are often for “pharmaceutical and medical device companies.” I’m not capable of stress testing such a piece of software, but I kicked the tires slightly by asking Claude to generate doctor’s notes that are very bad and irresponsible (I said it was just a movie prop). ©OpenEvidence When I told OpenEvidence those were my notes and asked it to make sure they were good, thankfully, it confirmed that they were bad, saying in part:
“This clinical documentation raises serious patient safety concerns. The presentation described contains multiple red flags for subarachnoid hemorrhage (SAH) that appear to have been insufficiently weighted, and the current management plan could result in significant harm.” So that’s somewhat comforting. On the other hand, according to NBC: “[…]some healthcare providers were quick to point out that OpenEvidence occasionally flubbed or exaggerated its answers, particularly on rare conditions or in ‘edge’ cases.” NBC’s report also clocked some worries within the medical community and elsewhere, in particular, a “lack of rigorous scientific studies on the tool’s patient impact,” and signs that OpenEvidence might be stunting the intellectual development of recent med school grads: “One midcareer doctor in Missouri, who requested anonymity given the limited number of providers in their medical field in the country, said he was already seeing the detrimental effects of OpenEvidence on students’ ability to sort signals from noise. ‘My worry is that when we introduce a new tool, any kind of tool that is doing part of your skills that you had trained up for a while beforehand, you start losing those skills pretty quickly” At a recent doctor’s appointment, my doctor asked my permission to use an AI tool on their phone (I don’t know if it was OpenEvidence). I didn’t know what to say other than yes. Do I want that for my doctor’s appointment? Not especially. But if my doctor has come to rely on a tool like this, then what am I supposed to do? Take away their crutch? #Doctor #Consulting #Free #Chatbot #ReportArtificial intelligence,doctors,Medicine")
![Your Doctor Is Most Likely Consulting This Free AI Chatbot, Report Says
How would you like it if, when stumped or just in need of some help with an unfamiliar situation, your doctor consulted a free, ad-supported AI chatbot? That’s not actually a hypothetical. They probably are doing that, a new report from NBC News says. It’s called OpenEvidence, and NBC says it was “used by about 65% of U.S. doctors across almost 27 million clinical encounters in April alone.” An earlier Bloomberg report on OpenEvidence from seven months ago said it had signed up 50% of American doctors at the time—so reported growth is rapid.
The OpenEvidence homepage trumpets the bot as “America’s Official Medical Knowledge Platform,” and says healthcare professionals qualify for unlimited free use, but non-doctors can try it for free without creating accounts. It gives long, detailed answers with extensive citations that superficially look—to me, a non-doctor—trustworthy and credible. NBC interviewed doctors for its story, and apparently pressed them on how often they actually click those links to the sources of information, and “most said they only do so when they get an unexpected result,” NBC’s report says.
While it’s free, OpenEvidence is not a charity. It’s a Miami-headquartered tech unicorn with a billionaire founder named David Nadler, and as of January it boasted a billion valuation. NBC says it’s backed by some of the all stars of Sand Hill Road: Sequoia Capital and Andreessen Horowitz, along with Google Ventures, Thrive Capital, and Nvidia.
And its revenue comes from ads (for now), which NBC says are often for “pharmaceutical and medical device companies.” I’m not capable of stress testing such a piece of software, but I kicked the tires slightly by asking Claude to generate doctor’s notes that are very bad and irresponsible (I said it was just a movie prop). ©OpenEvidence When I told OpenEvidence those were my notes and asked it to make sure they were good, thankfully, it confirmed that they were bad, saying in part:
“This clinical documentation raises serious patient safety concerns. The presentation described contains multiple red flags for subarachnoid hemorrhage (SAH) that appear to have been insufficiently weighted, and the current management plan could result in significant harm.” So that’s somewhat comforting. On the other hand, according to NBC: “[…]some healthcare providers were quick to point out that OpenEvidence occasionally flubbed or exaggerated its answers, particularly on rare conditions or in ‘edge’ cases.” NBC’s report also clocked some worries within the medical community and elsewhere, in particular, a “lack of rigorous scientific studies on the tool’s patient impact,” and signs that OpenEvidence might be stunting the intellectual development of recent med school grads: “One midcareer doctor in Missouri, who requested anonymity given the limited number of providers in their medical field in the country, said he was already seeing the detrimental effects of OpenEvidence on students’ ability to sort signals from noise. ‘My worry is that when we introduce a new tool, any kind of tool that is doing part of your skills that you had trained up for a while beforehand, you start losing those skills pretty quickly” At a recent doctor’s appointment, my doctor asked my permission to use an AI tool on their phone (I don’t know if it was OpenEvidence). I didn’t know what to say other than yes. Do I want that for my doctor’s appointment? Not especially. But if my doctor has come to rely on a tool like this, then what am I supposed to do? Take away their crutch? #Doctor #Consulting #Free #Chatbot #ReportArtificial intelligence,doctors,Medicine](https://gizmodo.com/app/uploads/2026/05/Screenshot-2026-05-13-at-8.02.01 PM.jpg "Your Doctor Is Most Likely Consulting This Free AI Chatbot, Report Says
How would you like it if, when stumped or just in need of some help with an unfamiliar situation, your doctor consulted a free, ad-supported AI chatbot? That’s not actually a hypothetical. They probably are doing that, a new report from NBC News says. It’s called OpenEvidence, and NBC says it was “used by about 65% of U.S. doctors across almost 27 million clinical encounters in April alone.” An earlier Bloomberg report on OpenEvidence from seven months ago said it had signed up 50% of American doctors at the time—so reported growth is rapid.
The OpenEvidence homepage trumpets the bot as “America’s Official Medical Knowledge Platform,” and says healthcare professionals qualify for unlimited free use, but non-doctors can try it for free without creating accounts. It gives long, detailed answers with extensive citations that superficially look—to me, a non-doctor—trustworthy and credible. NBC interviewed doctors for its story, and apparently pressed them on how often they actually click those links to the sources of information, and “most said they only do so when they get an unexpected result,” NBC’s report says.
While it’s free, OpenEvidence is not a charity. It’s a Miami-headquartered tech unicorn with a billionaire founder named David Nadler, and as of January it boasted a billion valuation. NBC says it’s backed by some of the all stars of Sand Hill Road: Sequoia Capital and Andreessen Horowitz, along with Google Ventures, Thrive Capital, and Nvidia.
And its revenue comes from ads (for now), which NBC says are often for “pharmaceutical and medical device companies.” I’m not capable of stress testing such a piece of software, but I kicked the tires slightly by asking Claude to generate doctor’s notes that are very bad and irresponsible (I said it was just a movie prop). ©OpenEvidence When I told OpenEvidence those were my notes and asked it to make sure they were good, thankfully, it confirmed that they were bad, saying in part:
“This clinical documentation raises serious patient safety concerns. The presentation described contains multiple red flags for subarachnoid hemorrhage (SAH) that appear to have been insufficiently weighted, and the current management plan could result in significant harm.” So that’s somewhat comforting. On the other hand, according to NBC: “[…]some healthcare providers were quick to point out that OpenEvidence occasionally flubbed or exaggerated its answers, particularly on rare conditions or in ‘edge’ cases.” NBC’s report also clocked some worries within the medical community and elsewhere, in particular, a “lack of rigorous scientific studies on the tool’s patient impact,” and signs that OpenEvidence might be stunting the intellectual development of recent med school grads: “One midcareer doctor in Missouri, who requested anonymity given the limited number of providers in their medical field in the country, said he was already seeing the detrimental effects of OpenEvidence on students’ ability to sort signals from noise. ‘My worry is that when we introduce a new tool, any kind of tool that is doing part of your skills that you had trained up for a while beforehand, you start losing those skills pretty quickly” At a recent doctor’s appointment, my doctor asked my permission to use an AI tool on their phone (I don’t know if it was OpenEvidence). I didn’t know what to say other than yes. Do I want that for my doctor’s appointment? Not especially. But if my doctor has come to rely on a tool like this, then what am I supposed to do? Take away their crutch? #Doctor #Consulting #Free #Chatbot #ReportArtificial intelligence,doctors,Medicine")
![Hey Dave Filoni, Leslye Headland Is Still Down for ‘The Acolyte’ Season 2
No matter what you thought about The Acolyte season one, there is no denying that season two was going to be incredible. Creator Leslye Headland and her team ended that first season with the promise of exploring multiple Dark Side relationships, the reveal of potentially the ultimate Sith in Darth Plagueis, a deep dive into the corruption of the Jedi, and even Yoda’s complicity in it. But, of course, that didn’t happen. Instead, Disney decided not to move forward with more episodes of The Acolyte. A true disappointment to fans of the show, but not all that surprising. The show, of course, had invited all manner of vitriol, and it seems like viewership didn’t quite justify the cost of more episodes. However, in the years since, the show has endured. In fact, just recently, there were reports that it once again cracked the top 10 on Disney+. And, in a new interview, Headland said that she’d still be interested in returning to a galaxy far, far, away. “I would still want to do it! Absolutely,” she told Empire, via Fantha Tracks. “As more people discover it, I think people may want to see some form of the story come back. We did have a lot of stuff that we wanted to explore, including tying in lore to the sequels. Getting into who exactly Manny [Jacinto]’s character is, his connection with [Jedi Master] Vernestra, his connection with [Sith Lord] Plagueis, and then his connection with other sequel-established things.”
Headland went on to say that she’s also felt the show returning a bit in recent days. “I’m having a resurgence of The Acolyte in my real life,” she said. “I speak with people who are really big fans, and were disappointed in the cancellation. was like, I went to a play last night, and somebody ‘I just have to tell you that I loved it.’”
We loved it too and think a second season would be absolutely incredible. Who wouldn’t want to see The Stranger with his new apprentice, and how that works with his master, Plagueis? Or what lengths the Jedi will go to in order to cover it all up? Hey, Lucasfilm president Dave Filoni, take note! Want more io9 news? Check out when to expect the latest Marvel, Star Wars, and Star Trek releases, what’s next for the DC Universe on film and TV, and everything you need to know about the future of Doctor Who. #Hey #Dave #Filoni #Leslye #Headland #Acolyte #SeasonDave Filoni,Leslye Headland,Star Wars,The Acolyte](https://i1.wp.com/gizmodo.com/app/uploads/2026/06/Acolyte-star-wars-lightsabers-1280x853.jpg?ssl=1 "Hey Dave Filoni, Leslye Headland Is Still Down for ‘The Acolyte’ Season 2
No matter what you thought about The Acolyte season one, there is no denying that season two was going to be incredible. Creator Leslye Headland and her team ended that first season with the promise of exploring multiple Dark Side relationships, the reveal of potentially the ultimate Sith in Darth Plagueis, a deep dive into the corruption of the Jedi, and even Yoda’s complicity in it. But, of course, that didn’t happen. Instead, Disney decided not to move forward with more episodes of The Acolyte. A true disappointment to fans of the show, but not all that surprising. The show, of course, had invited all manner of vitriol, and it seems like viewership didn’t quite justify the cost of more episodes. However, in the years since, the show has endured. In fact, just recently, there were reports that it once again cracked the top 10 on Disney+. And, in a new interview, Headland said that she’d still be interested in returning to a galaxy far, far, away. “I would still want to do it! Absolutely,” she told Empire, via Fantha Tracks. “As more people discover it, I think people may want to see some form of the story come back. We did have a lot of stuff that we wanted to explore, including tying in lore to the sequels. Getting into who exactly Manny [Jacinto]’s character is, his connection with [Jedi Master] Vernestra, his connection with [Sith Lord] Plagueis, and then his connection with other sequel-established things.”
Headland went on to say that she’s also felt the show returning a bit in recent days. “I’m having a resurgence of The Acolyte in my real life,” she said. “I speak with people who are really big fans, and were disappointed in the cancellation. was like, I went to a play last night, and somebody ‘I just have to tell you that I loved it.’”
We loved it too and think a second season would be absolutely incredible. Who wouldn’t want to see The Stranger with his new apprentice, and how that works with his master, Plagueis? Or what lengths the Jedi will go to in order to cover it all up? Hey, Lucasfilm president Dave Filoni, take note! Want more io9 news? Check out when to expect the latest Marvel, Star Wars, and Star Trek releases, what’s next for the DC Universe on film and TV, and everything you need to know about the future of Doctor Who. #Hey #Dave #Filoni #Leslye #Headland #Acolyte #SeasonDave Filoni,Leslye Headland,Star Wars,The Acolyte")
![Hey Dave Filoni, Leslye Headland Is Still Down for ‘The Acolyte’ Season 2
No matter what you thought about The Acolyte season one, there is no denying that season two was going to be incredible. Creator Leslye Headland and her team ended that first season with the promise of exploring multiple Dark Side relationships, the reveal of potentially the ultimate Sith in Darth Plagueis, a deep dive into the corruption of the Jedi, and even Yoda’s complicity in it. But, of course, that didn’t happen. Instead, Disney decided not to move forward with more episodes of The Acolyte. A true disappointment to fans of the show, but not all that surprising. The show, of course, had invited all manner of vitriol, and it seems like viewership didn’t quite justify the cost of more episodes. However, in the years since, the show has endured. In fact, just recently, there were reports that it once again cracked the top 10 on Disney+. And, in a new interview, Headland said that she’d still be interested in returning to a galaxy far, far, away. “I would still want to do it! Absolutely,” she told Empire, via Fantha Tracks. “As more people discover it, I think people may want to see some form of the story come back. We did have a lot of stuff that we wanted to explore, including tying in lore to the sequels. Getting into who exactly Manny [Jacinto]’s character is, his connection with [Jedi Master] Vernestra, his connection with [Sith Lord] Plagueis, and then his connection with other sequel-established things.”
Headland went on to say that she’s also felt the show returning a bit in recent days. “I’m having a resurgence of The Acolyte in my real life,” she said. “I speak with people who are really big fans, and were disappointed in the cancellation. was like, I went to a play last night, and somebody ‘I just have to tell you that I loved it.’”
We loved it too and think a second season would be absolutely incredible. Who wouldn’t want to see The Stranger with his new apprentice, and how that works with his master, Plagueis? Or what lengths the Jedi will go to in order to cover it all up? Hey, Lucasfilm president Dave Filoni, take note! Want more io9 news? Check out when to expect the latest Marvel, Star Wars, and Star Trek releases, what’s next for the DC Universe on film and TV, and everything you need to know about the future of Doctor Who. #Hey #Dave #Filoni #Leslye #Headland #Acolyte #SeasonDave Filoni,Leslye Headland,Star Wars,The Acolyte](https://gizmodo.com/app/uploads/2026/06/Acolyte-star-wars-lightsabers-1280x853.jpg "Hey Dave Filoni, Leslye Headland Is Still Down for ‘The Acolyte’ Season 2
No matter what you thought about The Acolyte season one, there is no denying that season two was going to be incredible. Creator Leslye Headland and her team ended that first season with the promise of exploring multiple Dark Side relationships, the reveal of potentially the ultimate Sith in Darth Plagueis, a deep dive into the corruption of the Jedi, and even Yoda’s complicity in it. But, of course, that didn’t happen. Instead, Disney decided not to move forward with more episodes of The Acolyte. A true disappointment to fans of the show, but not all that surprising. The show, of course, had invited all manner of vitriol, and it seems like viewership didn’t quite justify the cost of more episodes. However, in the years since, the show has endured. In fact, just recently, there were reports that it once again cracked the top 10 on Disney+. And, in a new interview, Headland said that she’d still be interested in returning to a galaxy far, far, away. “I would still want to do it! Absolutely,” she told Empire, via Fantha Tracks. “As more people discover it, I think people may want to see some form of the story come back. We did have a lot of stuff that we wanted to explore, including tying in lore to the sequels. Getting into who exactly Manny [Jacinto]’s character is, his connection with [Jedi Master] Vernestra, his connection with [Sith Lord] Plagueis, and then his connection with other sequel-established things.”
Headland went on to say that she’s also felt the show returning a bit in recent days. “I’m having a resurgence of The Acolyte in my real life,” she said. “I speak with people who are really big fans, and were disappointed in the cancellation. was like, I went to a play last night, and somebody ‘I just have to tell you that I loved it.’”
We loved it too and think a second season would be absolutely incredible. Who wouldn’t want to see The Stranger with his new apprentice, and how that works with his master, Plagueis? Or what lengths the Jedi will go to in order to cover it all up? Hey, Lucasfilm president Dave Filoni, take note! Want more io9 news? Check out when to expect the latest Marvel, Star Wars, and Star Trek releases, what’s next for the DC Universe on film and TV, and everything you need to know about the future of Doctor Who. #Hey #Dave #Filoni #Leslye #Headland #Acolyte #SeasonDave Filoni,Leslye Headland,Star Wars,The Acolyte")
Post Comment